NCT00739024View on ClinicalTrials.gov

A Study of a Melatonin Receptor Agonist to Prevent Migraine

PHASE2TerminatedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

September 30, 2010

Conditions

MigraineMigraine With AuraMigraine Without Aura

Interventions

DRUG

Ramelteon

8 mg tablet, oral, once daily

DRUG

Placebo

Placebo tablet, oral, once daily

Trial Locations (1)

98104

Swedish Pain and Headache Center, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Takeda

INDUSTRY

lead

Swedish Medical Center

OTHER